These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 35402232)
1. Chronic Stress Does Not Influence the Survival of Mouse Models of Glioblastoma. Lopes M; Vieira de Castro J; Pojo M; Gonçalves CS; Martins EP; Coimbra B; Sotiropoulos I; Sousa N; Rodrigues AJ; Costa BM Front Oncol; 2022; 12():856210. PubMed ID: 35402232 [TBL] [Abstract][Full Text] [Related]
2. ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma. Zhang C; Burger MC; Jennewein L; Genßler S; Schönfeld K; Zeiner P; Hattingen E; Harter PN; Mittelbronn M; Tonn T; Steinbach JP; Wels WS J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26640245 [TBL] [Abstract][Full Text] [Related]
3. Implantation of GL261 neurospheres into C57/BL6 mice: a more reliable syngeneic graft model for research on glioma-initiating cells. Yi L; Zhou C; Wang B; Chen T; Xu M; Xu L; Feng H Int J Oncol; 2013 Aug; 43(2):477-84. PubMed ID: 23708048 [TBL] [Abstract][Full Text] [Related]
4. Intracranial AAV-sTRAIL combined with lanatoside C prolongs survival in an orthotopic xenograft mouse model of invasive glioblastoma. Crommentuijn MH; Maguire CA; Niers JM; Vandertop WP; Badr CE; Würdinger T; Tannous BA Mol Oncol; 2016 Apr; 10(4):625-34. PubMed ID: 26708508 [TBL] [Abstract][Full Text] [Related]
5. Mouse models of glioblastoma for the evaluation of novel therapeutic strategies. Haddad AF; Young JS; Amara D; Berger MS; Raleigh DR; Aghi MK; Butowski NA Neurooncol Adv; 2021; 3(1):vdab100. PubMed ID: 34466804 [TBL] [Abstract][Full Text] [Related]
6. Metronomic treatment in immunocompetent preclinical GL261 glioblastoma: effects of cyclophosphamide and temozolomide. Ferrer-Font L; Arias-Ramos N; Lope-Piedrafita S; Julià-Sapé M; Pumarola M; Arús C; Candiota AP NMR Biomed; 2017 Sep; 30(9):. PubMed ID: 28570014 [TBL] [Abstract][Full Text] [Related]
7. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma. Shwetha SD; Shastry AH; Arivazhagan A; Santosh V Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112 [TBL] [Abstract][Full Text] [Related]
8. Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-Like Cell Models. Saha D; Wakimoto H; Peters CW; Antoszczyk SJ; Rabkin SD; Martuza RL Clin Cancer Res; 2018 Jul; 24(14):3409-3422. PubMed ID: 29599413 [No Abstract] [Full Text] [Related]
9. Crosstalk between glial and glioblastoma cells triggers the "go-or-grow" phenotype of tumor cells. Oliveira AI; Anjo SI; Vieira de Castro J; Serra SC; Salgado AJ; Manadas B; Costa BM Cell Commun Signal; 2017 Oct; 15(1):37. PubMed ID: 28969644 [TBL] [Abstract][Full Text] [Related]
10. Non-tumor cell IDO1 predominantly contributes to enzyme activity and response to CTLA-4/PD-L1 inhibition in mouse glioblastoma. Zhai L; Ladomersky E; Dostal CR; Lauing KL; Swoap K; Billingham LK; Gritsina G; Wu M; McCusker RH; Binder DC; Wainwright DA Brain Behav Immun; 2017 May; 62():24-29. PubMed ID: 28179106 [TBL] [Abstract][Full Text] [Related]
11. Immunovirotherapy with measles virus strains in combination with anti-PD-1 antibody blockade enhances antitumor activity in glioblastoma treatment. Hardcastle J; Mills L; Malo CS; Jin F; Kurokawa C; Geekiyanage H; Schroeder M; Sarkaria J; Johnson AJ; Galanis E Neuro Oncol; 2017 Apr; 19(4):493-502. PubMed ID: 27663389 [TBL] [Abstract][Full Text] [Related]
12. Gonçalves CS; Vieira de Castro J; Pojo M; Martins EP; Queirós S; Chautard E; Taipa R; Pires MM; Pinto AA; Pardal F; Custódia C; Faria CC; Clara C; Reis RM; Sousa N; Costa BM Theranostics; 2018; 8(17):4805-4823. PubMed ID: 30279739 [TBL] [Abstract][Full Text] [Related]
13. Brain Distribution and Efficacy of the Brain Penetrant PI3K Inhibitor GDC-0084 in Orthotopic Mouse Models of Human Glioblastoma. Salphati L; Alicke B; Heffron TP; Shahidi-Latham S; Nishimura M; Cao T; Carano RA; Cheong J; Greve J; Koeppen H; Lau S; Lee LB; Nannini-Pepe M; Pang J; Plise EG; Quiason C; Rangell L; Zhang X; Gould SE; Phillips HS; Olivero AG Drug Metab Dispos; 2016 Dec; 44(12):1881-1889. PubMed ID: 27638506 [TBL] [Abstract][Full Text] [Related]
14. Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2 Chu Y; Nayyar G; Jiang S; Rosenblum JM; Soon-Shiong P; Safrit JT; Lee DA; Cairo MS J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34244307 [TBL] [Abstract][Full Text] [Related]
15. Intracranial AAV-IFN-β gene therapy eliminates invasive xenograft glioblastoma and improves survival in orthotopic syngeneic murine model. GuhaSarkar D; Neiswender J; Su Q; Gao G; Sena-Esteves M Mol Oncol; 2017 Feb; 11(2):180-193. PubMed ID: 28098415 [TBL] [Abstract][Full Text] [Related]
17. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration. Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830 [TBL] [Abstract][Full Text] [Related]
18. Shevtsov M; Pitkin E; Ischenko A; Stangl S; Khachatryan W; Galibin O; Edmond S; Lobinger D; Multhoff G Front Immunol; 2019; 10():454. PubMed ID: 30967859 [TBL] [Abstract][Full Text] [Related]
19. Autotaxin Inhibition with PF-8380 Enhances the Radiosensitivity of Human and Murine Glioblastoma Cell Lines. Bhave SR; Dadey DY; Karvas RM; Ferraro DJ; Kotipatruni RP; Jaboin JJ; Hallahan AN; Dewees TA; Linkous AG; Hallahan DE; Thotala D Front Oncol; 2013; 3():236. PubMed ID: 24062988 [TBL] [Abstract][Full Text] [Related]
20. Glucose fluxes in glycolytic and oxidative pathways detected in vivo by deuterium magnetic resonance spectroscopy reflect proliferation in mouse glioblastoma. Simões RV; Henriques RN; Cardoso BM; Fernandes FF; Carvalho T; Shemesh N Neuroimage Clin; 2022; 33():102932. PubMed ID: 35026626 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]